Global Blood Therapeutics

Showing 4 posts of 4 posts found.

oxbryta-bottle-and-pills

EMA accepts Global Blood Therapeutics’ MAA for Oxbryta

January 28, 2021
Global Blood Therapeutics

The EMA has accepted Global Blood Therapeutics (GBT)’s Marketing Authorisation Application (MAA) for Oxbryta (voxelotor) tablets, and has started its …

Novo Nordisk eyes acquisition of Global Blood Therapeutics

March 9, 2017
Sales and Marketing Global Blood Therapeutics, Novo Nordisk

Novo Nordisk has been notoriously shy when it comes to making acquisitions but Reuters has reported that this may be …

stocks1

Weekly Movers: Global Blood Therapeutics, Sophiris Bio…

June 20, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Global Blood Therapeutics, Shares, markets, pharma, stocks

Here’s a quick look at some of the biggest movers of the week:Sophiris Bio (Nasdaq: SPHS) stock rose to nearly …

globalblood

Shares in Global Blood jump after positive results for trial sickle cell drug

June 13, 2016
Research and Development, Sales and Marketing Global Blood Therapeutics, drug trial, sickle cell disease

Global Blood Therapeutics (Nasdaq: GBT) shares jumped to close up over 9% Friday after the company said its trial drug …

Latest content